Blueprint Medicines Corporation (2L9.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:17AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 6.07B |
| Enterprise Value | 5.77B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 22.86 |
| Price/Book (mrq) | 21.15 |
| Enterprise Value/Revenue | 21.92 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.70 |
| 52-Week Change 3 | 74.86% |
| S&P500 52-Week Change 3 | 24.71% |
| 52 Week High 3 | 102.00 |
| 52 Week Low 3 | 41.20 |
| 50-Day Moving Average 3 | 92.62 |
| 200-Day Moving Average 3 | 73.58 |
Share Statistics
| Avg Vol (3 month) 3 | 75 |
| Avg Vol (10 day) 3 | 55 |
| Shares Outstanding 5 | 62.62M |
| Implied Shares Outstanding 6 | 64.43M |
| Float 8 | 61.9M |
| % Held by Insiders 1 | 0.92% |
| % Held by Institutions 1 | 106.96% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -102.15% |
| Operating Margin (ttm) | -82.01% |
Management Effectiveness
| Return on Assets (ttm) | -24.40% |
| Return on Equity (ttm) | -79.53% |
Income Statement
| Revenue (ttm) | 282.21M |
| Revenue Per Share (ttm) | 4.63 |
| Quarterly Revenue Growth (yoy) | 51.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -428.1M |
| Net Income Avi to Common (ttm) | -288.29M |
| Diluted EPS (ttm) | -4.49 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 647.9M |
| Total Cash Per Share (mrq) | 10.35 |
| Total Debt (mrq) | 597.93M |
| Total Debt/Equity (mrq) | 192.46% |
| Current Ratio (mrq) | 3.76 |
| Book Value Per Share (mrq) | 4.96 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -415.4M |
| Levered Free Cash Flow (ttm) | -262.51M |
© 2024 Yahoo. All rights reserved.